YPSOMED is a Swiss based developer and manufacturer of self-injection devices with nearly 40 years of experience and numerous high precision and high quality devices on the global market. Ypsomed provides a complete range of technologies and services for reliable and user-friendly self-injection systems for injectables such as insulin, GLP-1, hGH and mAbs. Our customers are pharmaceutical and biotechnology companies worldwide that develop, manufacture and market medications for self-injection.
Year Established: 1984
Total Assets(USD): choose not to disclose
Total Number of Staff: more than 500
Annual Turnover(USD) : choose not to disclose
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
AutoInjector YpsoMate
Disposbale Injection Pen UnoPen
Reusable Injection Pen YpsoPen